CMS Just Changed the Playbook for GLP-1...Consider the Following

So what happened in May, May 1st? Well, on that date, state Medicaid agencies got permission to start joining a program called the Balance Model or Balance in short.

And balance is a new way to help people get GLP-1 drugs for obesity and related diseases.

So very important to a very large population in the U.S. And just a few weeks from now, on July 1st, 2026, another big change happens.

People with Medicare Part D will be able to get GLP-1s for $50 a month through a process called the Medicare GLP-1 Bridge.

And in January 2027, the full balance model will roll out nationwide for Medicare Part D.

Now, you may want to look beyond Novo and Lilly, because those are the ones we're probably most familiar with, given the GLPs that they provide.

Most of the conversation regarding GLP-1 so far is focused on those guys, right? The two biggies in that space, Novo Nordisk and Eli Lilly.

They were the first to sign up with CMS.

That makes sense since, like I said, they're two of the biggest GLP-1 providers.

But the focus misses something important if that's all you focus on.

Balance is not just a deal between CMS and two drug companies.

It's a structural shift related to how GLP-1 drugs move through the American healthcare system.

And that shift creates new risks, of course, but also very new opportunities that are very popular and are going to be very important for many other kinds of companies, including small pharma companies, early stage biotech.

Digital health companies, home health agencies, hospitals, associations for doctors and providers who are about to see their patient list change, by the way.

And when you think of GLP-1s, these are not some of the areas you're probably thinking about.

So we're going to dig deeper into that through the core of today's discussion.

But if you do work for any of these organizations and haven't yet thought about what balance means for your business, today is a good day to start that.

So let me explain exactly what balance is and why timing matters if you want to take advantage of a unique and rarely available opportunity.

Let's go through the basics of balance because the details will matter for your business strategy.

Balance stands for Better Approaches to Lifestyle and Nutrition for Comprehensive Health.

It's a voluntary program run by the CMS Innovation Center.

That means drug companies, state Medicaid agencies, and Medicare plans can choose to join Balance.

but they don't have to.

Here's how it works.

CMS negotiates directly with the GLP-1 manufacturers for lower prices and clear coverage rules.